Complement protein isoforms in CSF as possible biomarkers for neurodegenerative disease

Area of Science:

• Neuroscience
• Immunology
• Biochemistry

Background:

• The complement system, a key part of innate immunity, is implicated in the pathogenesis of neurodegenerative diseases.
• Previous research suggests complement activation contributes to Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS).

Purpose of the Study:

• To compare cerebrospinal fluid (CSF) expression levels of specific complement proteins (C3b, C4b, factor B, factor H) between healthy individuals and patients with AD, PD, MS, and neurosyphilis.
• To investigate the diagnostic potential of individual complement protein isoforms in neurodegenerative diseases.

Main Methods:

• Cerebrospinal fluid (CSF) proteins were separated using two-dimensional gel electrophoresis.
• Expression levels of complement proteins C3b, C4b, factor B, and factor H were quantified and compared across disease groups and controls.
• Statistical analysis (p < 0.05) was used to identify significant changes in isoform expression.

Main Results:

• Patients with AD, PD, and MS exhibited significant changes in the CSF expression levels of multiple complement isoforms compared to normal subjects.
• Parkinson's disease (PD) patients showed the most numerous significant changes, characterized by decreased expression of several complement isoforms in CSF.
• The examined complement isoforms demonstrated the ability to differentiate between certain, but not all, of the studied neurological conditions.

Conclusions:

• Individual complement protein isoform expression levels in CSF differ significantly in patients with AD, PD, and MS compared to controls.
• Analyzing specific protein isoforms, rather than total protein levels, may enhance the utility of biomarkers for diagnosing neurodegenerative diseases.
• Complement system dysregulation is a potential factor in the pathophysiology of these neurological disorders.